Turning Point Therapeutics

-$5.79 (-8.20%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell TPTX and other stocks, options, and ETFs commission-free!

About TPTX

Turning Point Therapeutics, Inc. Common Stock, also called Turning Point Therapeutics, is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients.

CEO
Athena Countouriotis
Employees
142
Headquarters
San Diego, California
Founded
2013

TPTX Key Statistics

Market Cap
3.48B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
571.87K
High Today
$69.89
Low Today
$63.83
Open Price
$69.50
Volume
825.51K
52 Week High
$141.30
52 Week Low
$51.56

TPTX Earnings

-$1.02
-$0.82
-$0.62
-$0.42
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.61 per share
Actual
-$0.73 per share
Replay Earnings Call

You May Also Like

MTBCP
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure